Signorelli SS et al. |
A randomised, controlled clinical trial evaluating changes in therapeutic efficacy and oxidative parameters after treatment with propionyl L-carnitine in patients with peripheral arterial disease requiring haemodialysis. |
2006 |
Drugs Aging |
pmid:16608381
|
Santo SS et al. |
Effect of PLC on functional parameters and oxidative profile in type 2 diabetes-associated PAD. |
2006 |
Diabetes Res. Clin. Pract. |
pmid:16446007
|
Al-Majed AA et al. |
Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. |
2006 |
Pharmacol. Res. |
pmid:16436331
|
Bene J et al. |
Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis. |
2006 |
World J. Gastroenterol. |
pmid:16440427
|
Origlia N et al. |
Protective effect of L-propionylcarnitine in chronic cyclosporine-a induced nephrotoxicity. |
2006 |
Biomed. Pharmacother. |
pmid:16472963
|
Loffredo L et al. |
Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. |
2006 |
J. Vasc. Surg. |
pmid:16950429
|
Al-Majed AA et al. |
Carnitine esters prevent oxidative stress damage and energy depletion following transient forebrain ischaemia in the rat hippocampus. |
2006 |
Clin. Exp. Pharmacol. Physiol. |
pmid:16895547
|
Signorelli SS et al. |
Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease. |
2006 |
Kidney Blood Press. Res. |
pmid:16809937
|
Lango R et al. |
Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients. |
2005 |
Cardiovasc Drugs Ther |
pmid:16187006
|
Campbell CD et al. |
Two newborns with nutritional vitamin B12 deficiency: challenges in newborn screening for vitamin B12 deficiency. |
2005 |
Haematologica |
pmid:16464760
|